A Food Chemist'S View of Advanced Glycation End-Products

Maillard L.C. Action des acides aminés sur les sucres. Formation des mélanoidines par voi méthodique. C R Acad Sci I 1912; 154: 66–68.

Ledl F. , Schleicher E. New aspects of the Maillard reaction in food and in the human body. Angew Chem Int Ed Engl 1990; 29: 565–94.

Thorpe S.R. , Baynes J.W. Role of the Maillard reaction in diabetes mellitus and aging. Drugs Aging 1996; 9: 69–77.

Friedman E.A. Advanced glycation end-products in diabetic nephropathy. Nephrol Dial Transplant 1999; 14(Suppl 3): 1–9.

Miyata T. , Oda O. , Inagi R. , Iida Y. , Araki N. , Yamada N. β₂-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. J Clin Invest 1993; 92: 1243–52.

Vlassara H. , Striker L.J. , Teichberg S. , Fuh H. , Li Y.M. , Steffes M. Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats. Proc Natl Acad Sci U S A 1994; 91: 11704–8.

Sakata N. , Imanaga Y. , Meng J. , Tachikawa Y. , Takebayashi S. , Nagai R. Increased advanced glycation end products in atherosclerotic lesions of patients with end-stage renal disease. Atherosclerosis 1999; 142: 67–77.

Fishbane S. , Bucala R. , Pereira B.J. , Founds H. , Vlassara H. Reduction of plasma apolipoprotein-B by effective removal of circulating glycation derivatives in uremia. Kidney Int 1997; 52: 1645–50.

Nakayama M. , Kawaguchi Y. , Yamada K. , Hasegawa T. , Takazoe K. , Katoh N. Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD. Kidney Int 1997; 51: 182–6.

Miyata T. , Iida Y. , Ueda Y. , Shinzato T. , Seo H. , Monnier V.M. Monocyte/macrophage response to β₂–micro-globulin modified with advanced glycation end products. Kidney Int 1996; 49: 538–50.

Thornalley P.J. Cell activation by glycated protein. AGE receptors, receptor recognition factors and functional classification of AGEs. Cell Mol Biol (Noisy-le-grand) 1998; 44: 1013–23.

Miyata T. , Wada Y. , Cai Z. Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure. Kidney Int 1997; 51: 1170–81.

Devuyst O. , van Ypersele de Strihou C. Nitric oxide, advanced glycation end products, and uremia. Kidney Int 2000; 58: 1814–15.

Asahi K. , Ichimori K. , Nakazawa H. , Izuhara Y. , Inagi R. , Watanabe T. Nitric oxide inhibits the formation of advanced glycation end products. Kidney Int 2000; 58: 1780–7.

Verbeke P. , Perichon M. , Friguet B. , Bakala H. Inhibition of nitric oxide synthase activity by early and advanced glycation end products in cultured rabbit proximal tubular epithelial cells. Biochim Biophys Acta 2000; 1502: 481–94.

Ritz E. , Deppisch R. , Nawroth P. Toxicity of uremia— does it come from AGE? Nephrol Dial Transplant 1994; 9: 1–2.

Vanholder R. , De Smet R. Pathophysiologic effect of uremic retention solutes. J Am Soc Nephrol 1999; 10: 1815–23.

Raj D.S. , Choudhury D. , Welbourne T.C. , Levi M. Advanced glycation end products: a nephrologist's perspective. Am J Kidney Dis 2000; 35: 365–80.

Oimomi M. , Nishimoto S. , Kitamura Y. , Matsumoto S. , Hatanaka H. , Ishikawa K. Increased fructoselysine of hair protein in diabetic patients. Klin Wochenschr 1985; 63: 728–30.

Ahmed M.U. , Thorpe S.R. , Baynes J.W. Identification of Nε-carboxymethyllysine as a degradation product of fructoselysine in glycated protein. J Biol Chem 1986; 261: 4889–94.

Portero–Otin M. , Nagaraj R.H. , Monnier V.M. Chromatographic evidence for pyrraline formation during protein glycation in vitro and in vivo. Biochim Biophys Acta 1995; 1247: 74–80.

Sell D.R. , Monnier V.M. Structure elucidation of a senescence cross-link from human extracellular matrix. Implication of pentoses in the aging process. J Biol Chem 1989; 264: 21597–602.

Odani H. , Shinzato T. , Usami J. , Matsumoto Y. , Brinkmann Frye E. , Baynes J.W. Imidazolium crosslinks derived from reaction of lysine with glyoxal and methylglyoxal are increased in serum proteins of uremic patients: evidence for increased oxidative stress in uremia. FEBS Lett 1998; 427: 381–5.

Glomb M.A. , Monnier V.M. Mechanism of protein modification by glyoxal and glycolaldehyde, reactive intermediates of the Maillard reaction. J Biol Chem 1995; 270: 10017–26.

Ledl F. , Osiander H. , Pachmayr O. , Severin T.H. Formation of maltosine, a product of the Maillard reaction with a pyridone structure. Z Lebensm Unters Forsch 1989; 188: 207–11.

Westwood M.E. , Thornalley P.J. Molecular characteristics of methylglyoxal-modified bovine and human serum albumins. Comparison with glucose-derived advanced glycation endproduct-modified serum albumins. J Protein Chem 1995; 14: 359–72.

Schwarzenbolz U. , Henle T. , Haessner R. , Klostermeyer H. On the reaction of glyoxal with proteins. Z Lebensm Unters Forsch 1997; 205: 121–4.

Shipanova I.N. , Glomb M.A. , Nagaraj R.H. Protein modification by methylglyoxal: chemical nature and synthetic mechanism of a major fluorescent adduct. Arch Biochem Biophys 1997; 344: 29–36.

Obayashi H. , Nakano K. , Shigeta H. , Yamaguchi M. , Yoshimori K. , Fukui M. Formation of crossline as a fluorescent advanced glycation end product in vitro and in vivo. Biochem Biophys Res Commun 1996; 226: 37–41.

Franke S. , Niwa T. , Deuther–Conrad W. , Sommer M. , Hein G. , Stein G. Immunochemical detection of imidazolone in uremia and rheumatoid arthritis. Clin Chim Acta 2000; 300: 29–41.

Lederer M.O. , Buhler H.P. Cross-linking of proteins by Maillard processes: characterization and detection of a lysine–arginine cross-link derived from d-glucose. Bioorg Med Chem 1999; 7: 1081–8.

Hofmann T. , Bors W. , Stettmaier K. Radical-assisted melanoidin formation during thermal processing of foods as well as under physiological conditions. J Agric Food Chem 1999; 47: 391–6.

Prabhakaram M. , Mossine V.V. Characterization of a blue fluorophore isolated from in vitro reaction of N-acetyllysine and 3-deoxyglucosone. Prep Biochem Biotechnol 1998; 28: 319–38.

Nakamura K. , Nakazawa Y. , Ienaga K. Acid-stable fluorescent advanced glycation end products: vesperlysines A, B, and C are formed as crosslinked products in the Maillard reaction between lysine or proteins with glucose. Biochem Biophys Res Commun 1997; 232: 227–30.

Hayase F. , Koyama T. , Konishi Y. Novel dehydrofuroimidazole compounds formed by the advanced Maillard reaction of 3-deoxy-d-hexos-2-ulose and arginine residues in proteins. J Agric Food Chem 1997; 45: 1137–42.

Henle T. , Zehetner G. , Klostermeyer H. Fast and sensitive determination of furosine. Z Lebensm Unters Forsch 1995; 200: 235–8.

Henle T. , Walter A.W. , Haessner R. , Klostermeyer H. Isolation and identification of a protein-bound imidazolone resulting from the reaction of arginine residues and methylglyoxal. Z Lebensm Unters Forsch 1994; 199: 55–8.

Henle T. , Schwarzenbolz U. , Klostermeyer H. Detection and quantification of pentosidine in foods. Z Lebensm Unters Forsch 1997; 204: 95–8.

Henle T. , Deppisch R. , Beck W. , Hergesell O. , Hänsch G.M. , Ritz E. Advanced glycated end-products (AGE) during haemodialysis treatment: discrepant results with different methodologies reflecting the heterogeneity of AGE compounds. Nephrol Dial Transplant 1999; 14: 1968–75.

Henle T. , Deppisch R. , Ritz E. The Maillard reaction—from food chemistry to uremia research. Nephrol Dial Transplant 1996; 11: 1718–22.

Koschinsky T. , He C.J. , Metsuhashi T. Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy. Proc Natl Acad Sci U S A 1997; 94: 6474–9.

Lee K. , Erbersdobler H.F. Balance experiments on human volunteers with fructoselysine and lysinoalanine. In: Labuza T.P. , Reineccius G.A. , Monnier V.M. , O'Brien J. , Baynes J.W. , eds. Maillard Reactions in Chemistry, Food and Health. Proceedings of the Fifth International Symposium on the Maillard Reaction; 29 August – 1 September 1993; Minneapolis, MN. Cambridge: The Royal Society of Chemistry; 1994: 358–63.

Henle T. , Schwenger V. , Ritz E. Preliminary studies on the renal handling of lactuloselysine from milk products. Czech J Food Sci 2000; 18: S101–2.

Bergmann R. , Helling R. , Heichert C. , Scheunemann M. , Maeding P. , Wittrisch H. Radio fluorination and positron emission tomography (PET) as a new approach to study the in vivo distribution and elimination of the advanced glycation endproducts Nε-carboxymethyl-lysine (CML) and Nε-carboxyethyllysine (CEL). Nahrung 2001; 45: 182–8.